OMERS Acquires Majority Interest in Inmar
Apr 04, 2017 12:01 pm UTC| Business
Winston-Salem, NC, April 04, 2017 -- OMERS Private Equity ("OPE"), the private equity arm of OMERS, the pension plan for municipal employees in Ontario, has agreed to acquire Inmar Inc. from ABRY Partners, a private...
OMERS Acquires Majority Interest in Inmar
Apr 04, 2017 12:01 pm UTC| Business
Winston-Salem, NC, April 04, 2017 -- OMERS Private Equity ("OPE"), the private equity arm of OMERS, the pension plan for municipal employees in Ontario, has agreed to acquire Inmar Inc. from ABRY Partners, a private...
Apr 04, 2017 12:01 pm UTC| Business
HOUSTON, April 04, 2017 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced two...
Apr 04, 2017 12:01 pm UTC| Business
HOUSTON, April 04, 2017 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced two...
Apr 04, 2017 12:01 pm UTC| Business
Preclinical Study Presented at 2017 AACR Annual Meeting Pharmacokinetics of Sacituzumab Govitecan in Patients with Diverse Solid Tumors also Presented WASHINGTON, April 04, 2017 -- Immunomedics, Inc., (NASDAQ:IMMU)...
Apr 04, 2017 12:01 pm UTC| Business
Preclinical Study Presented at 2017 AACR Annual Meeting Pharmacokinetics of Sacituzumab Govitecan in Patients with Diverse Solid Tumors also Presented WASHINGTON, April 04, 2017 -- Immunomedics, Inc., (NASDAQ:IMMU)...
OMERS Private Equity acquires Inmar
Apr 04, 2017 12:01 pm UTC| Business
NEW YORK, April 04, 2017 -- OMERS Private Equity ("OPE"), the private equity arm of OMERS, the pension plan for municipal employees in Ontario, together with management, has agreed to acquire Inmar (“Inmar” or the...